In this study, KCs treated with ASC-CM showed an enhanced expression of CK16, while TGF-β1-treated and untreated KCs both demonstrated a lower number of CK16+ KCs (Figure 7A,B). The gene discussed is TGFB1; the disease is dry eye syndrome.